ST Dali Pharmaceutical announced that the raised funds originally invested in the 'Traditional Chinese Medicine Injection Secondary Development Research Project', 'Pharmaceutical Research and Development Technology Center Construction Project' sub-project 'Research Center Construction Project', and 'Marketing Network Construction Project' will be changed to be invested in the 'Dali Pharmaceutical Medicine Distribution Project' implemented by the company's wholly-owned subsidiary sales company. The amount of funds involved in this change is 129 million yuan, accounting for 49.10% of the total actual raised funds of the company.
*ST大药：拟将1.29亿元募集资金变更投向医药配送项目
*ST Dali Pharmaceutical intends to change 129 million yuan of raised funds to be invested in pharmaceutical distribution projects.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.